The 10th Ocular Diseases Drug Discovery Conference is taking place on March 21-22, 2018 in San Diego, CA. We are excited to have top representatives from the industry and academic sectors to discuss technologies and targets that are continually changing the way ocular diseases are treated. Drug delivery is always improving as we look at for better methods to penetrate anterior and poster segments of the eye. Successes in gene therapy and regenerative medicine are proving to be interesting approaches to discuss in detail pre-clinically and clinically. We are gathering leading scientists, researchers, and experts to discuss and collaborate on combating and curing age-related macular degeneration (AMD), dry eye, glaucoma, diabetic macular edema (DME), and other ocular diseases.
- Preclinical Development of Novel Technologies
- Translational Studies and Lessons Learned
- Partnering with Academia and CROs to Advance Research
- Panels on Funding and Regulatory Challenges
We hope to see you there!
The 2018 Advisory Committee
|2018 ADVISORY BOARD MEMBERS|
|Matthias Birkhoff, Aptar|
|Oscar Cuzzani, BioTime|
|Emmett Cunningham, Clarus Ventures|
|Rafal Farjo, EyeCRO LLC|
|Rangaramujam Kannan, John Hopkins University|
|Donald J. Alcendor, Vanderbilt University|
Amber Kempf at 626-256-6405 x110 or amber.kempf [at] gtcbio.com
For more information on Media Relations, please contact:
Jennifer Chu at 626-256-6405 x105 or jennifer.chu [at] gtcbio.com
The 2018 sponsorship is currently in process.
Please come back and visit this page for updates.
BELOW ARE THE SPONSORS FROM 2017.